SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : AMLN (DIABETES DRUGS) -- Ignore unavailable to you. Want to Upgrade?


To: D.Right who wrote (952)11/18/1997 9:49:00 PM
From: Henry Niman  Respond to of 2173
 
D. Right, Many companies are working on TZDs and PPARs. SBH and Takeda have 2nd generation compounds in advanced clinical trials. SBH's compound is as effective as Rezulin at 1/10 the dose. As I said before, Pramlintide is an analog of a polyprptide hormone and the various TZDs are analogs of a non-polypeptide hormone. They act through natural receptors and are not distinguished by "add on" definitions.